Claudia Vener

5PUBLICATIONS
40CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 14, 2026
Cancer Patients Mortality From Other Causes: A European Population-Based Study.

|Mar 28, 2026
Circulating microRNAs as Early Biomarkers of Breast Cancer: A Nested Case-Control Study Within a Prospective Cohort in Italy.

Lisa Padroni, Giorgia Marmiroli, Laura De Marco

|Nov 07, 2022
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients.

Ilaria Cutica, Silvia Riva, Ester Maria Orlandi

|Apr 12, 2022
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis.

Daniele Cattaneo, Claudia Vener, Elena Maria Elli

|Jun 02, 2021
Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial.

Carlo Pietrasanta, Andrea Ronchi, Claudia Vener

Pageof 1

Frequent Collaborators

2 joint publications

Daniele Cattaneo

1 joint publications

Carlo Pietrasanta

1 joint publications

Chiara Poggi

1 joint publications

Claudia Ballerini